These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Ga68-PSMA PET for lymph node staging in intermediate and high-risk prostate cancer patients undergoing robotic assisted radical prostatectomy. Spena G; Moretti TB; Dávila FS; Dos Anjos G; Khan I; Calace FP; Aveta A; Pandolfo SD; Tufano A; Izzo A; Farias A; Perdonà S; Maes K Minerva Urol Nephrol; 2024 Aug; 76(4):467-473. PubMed ID: 39051893 [TBL] [Abstract][Full Text] [Related]
10. Distribution of prostate cancer recurrences on gallium-68 prostate-specific membrane antigen ( Huits TH; Luiting HB; van der Poel HG; Nandurkar R; Donswijk M; Schaake E; Vogel W; Roobol MJ; Wit E; Stricker P; Emmett L; van Leeuwen PJ BJU Int; 2020 Jun; 125(6):876-883. PubMed ID: 32181951 [TBL] [Abstract][Full Text] [Related]
11. Preclinical Evaluation and First Patient Application of 99mTc-PSMA-I&S for SPECT Imaging and Radioguided Surgery in Prostate Cancer. Robu S; Schottelius M; Eiber M; Maurer T; Gschwend J; Schwaiger M; Wester HJ J Nucl Med; 2017 Feb; 58(2):235-242. PubMed ID: 27635024 [TBL] [Abstract][Full Text] [Related]
12. Gallium-68-prostate-specific membrane antigen ( van Leeuwen PJ; Donswijk M; Nandurkar R; Stricker P; Ho B; Heijmink S; Wit EMK; Tillier C; van Muilenkom E; Nguyen Q; van der Poel HG; Emmett L BJU Int; 2019 Jul; 124(1):62-68. PubMed ID: 30074667 [TBL] [Abstract][Full Text] [Related]
17. Prostate-Specific Membrane Antigen-Targeted Radioguided Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients with a Suspicion of Locoregional Lymph Node Metastases: The DETECT Trial. Schilham MGM; Somford DM; Küsters-Vandevelde HVN; Hermsen R; van Basten JPA; Hoekstra RJ; Scheenen TWJ; Gotthardt M; Sedelaar JPM; Rijpkema M J Nucl Med; 2024 Mar; 65(3):423-429. PubMed ID: 38176721 [TBL] [Abstract][Full Text] [Related]
18. Robot-assisted Prostate-specific Membrane Antigen-radioguided Salvage Surgery in Recurrent Prostate Cancer Using a DROP-IN Gamma Probe: The First Prospective Feasibility Study. de Barros HA; van Oosterom MN; Donswijk ML; Hendrikx JJMA; Vis AN; Maurer T; van Leeuwen FWB; van der Poel HG; van Leeuwen PJ Eur Urol; 2022 Jul; 82(1):97-105. PubMed ID: 35339318 [TBL] [Abstract][Full Text] [Related]
19. Lymph node staging with 68Ga-PSMA PET in patients with intermediate and high-risk prostate cancer suitable for radical prostatectomy managed in a prostate cancer unit. Maestroni UV; Campobasso D; Guarino G; Acampora A; Scarlattei M; Ziglioli F; Dinale F; Baldari G; Migliari S; Gasparro D; Ferretti S; Silini EM; Ruffini L Chin Clin Oncol; 2023 Jun; 12(3):22. PubMed ID: 37417288 [TBL] [Abstract][Full Text] [Related]
20. 67 Ga-PSMA I&T for Radioguided Surgery of Lymph Node Metastases in Patients With Biochemical Recurrence of Prostate Cancer. Winkens T; Berger FP; Foller S; Greiser J; Groeber S; Grimm MO; Freesmeyer M; Kuehnel C Clin Nucl Med; 2023 Jul; 48(7):600-607. PubMed ID: 37145416 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]